Itraconazole as a Targeted Therapy for Inhibiting Hedgehog Pathway Signaling in Esophageal Cancer Patients

NCT02749513 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

18

Enrollment

FED

Sponsor class

Conditions

Esophageal Cancer

Interventions

DRUG: Itraconazole

Sponsor

Dallas VA Medical Center